To the best of our knowledge, the present study is the first to examine the plasma levels of FABP4 in COPD patients and the correlations between FABP4 and adiponectin, inflammatory biomarkers and lung function. This evidence concerns the gene ADIPOQ and chronic obstructive pulmonary disease.